From Wikipedia, the free encyclopedia
Jump to: navigation, search
Fasinumab ?
Monoclonal antibody
Source Human
Target HNGF
Clinical data
Legal status
CAS number 1190239-42-9
ATC code None
Chemical data
Formula C6406H9896N1700O2026S46 
Mol. mass 144.6 kDa

Fasinumab is a human monoclonal antibody designed for the treatment of pain.[1] Fasinumab for acute sciatic pain[2]

This drug was developed by Regeneron Pharmaceuticals.


  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Fasinumab, American Medical Association.
  2. ^ http://www.dovepress.com/fasinumab-regn475-an-antinerve-growth-factor-monoclonal-antibody-for-t-peer-reviewed-article-JPR